Jasmine Hernandez
Otolaryngology · Cedar Rapids, IANPI 1487034617
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.4% of the total across 36 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 12 manufacturers, the largest accounting for just 20.9% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for otolaryngology clinicians in IA, where the typical reported total is $776.
Across 36 payments — averaging $21.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$162
- Acclarent, Inc$130
- Smith+Nephew$104
- Integra Lifesciences Corporation$102
- GSK$86
- Regeneron Healthcare Solutions, Inc.$65
- plus $126 from 6 others
What the payments were for
- Food & beverage$71792%
- Other$598%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 10 | $162 |
| Acclarent, Inc | 4 | $130 |
| Smith+Nephew | 4 | $104 |
| Integra Lifesciences Corporation | 2 | $102 |
| GSK | 6 | $86 |
| Regeneron Healthcare Solutions, Inc. | 3 | $65 |
| Aerin Medical Inc. | 2 | $47 |
| Amgen | 1 | $22 |
| Stryker | 1 | $19 |
| Medtronic | 1 | $13 |
| Merck | 1 | $13 |
| Kaleo, Inc. | 1 | $12 |
How this compares
$776 in reported general payments places this provider in the 50th percentile of 103 otolaryngology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 59 | $1,146 |
| Azelastine Hcl | 45 | $945 |
| Ofloxacin | 17 | $287 |
| Betamethasone Valerate | 17 | $272 |
| Fluticasone Propionate | 27 | $206 |
| Mupirocin | 23 | $174 |
| Omeprazole | 46 | $163 |
| Prednisone | 11 | $114 |
| Oxycodone Hcl | 20 | $89 |
| Montelukast Sodium | 12 | $48 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Cedar Rapids
- Thomas HeinemanCedar Rapids$373K
- Madia RussilloCedar Rapids$4K
- Andrew LiuCedar Rapids$3K
- Ryan DempewolfCedar Rapids$2K
- Bruce GantzIowa City$170K
- Nancy BaumanIowa City$31K
- Simon WrightWest Des Moines$21K
- Robert PettisOskaloosa$10K
- Brian AndrewsIowa City$9K
- Douglas HoisingtonWest Des Moines$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.